Format

Send to

Choose Destination
See comment in PubMed Commons below
Adv Drug Deliv Rev. 2001 Sep 1;50(3):245-59.

Bovine mastitis and intramammary drug delivery: review and perspectives.

Author information

  • 1CEVA Sante Animale, Research and Development, BP126, F-33501 Libourne cedex, France. philippe.gruet@cevavet.com

Abstract

Intramammary infections (IMIs) represent a major feature in bovine pathology. The treatment of IMIs concern antimicrobial substances. Therapeutic strategies involve administration of immediate release formulations during lactation with or without long-acting formulations during the dry period. Current treatments are not very successful and cure rates are poor, especially towards Staphylococcus aureus which is responsible for chronic infections and huge economic losses. New strategies have recently been investigated. These include particular immunomodulators like lysostaphin or cytokines, and novel formulations (e.g. liposomes, microparticles or nanoparticles) that allow uptake of the active component by phagocytes and thus prolong an enhanced antibacterial activity.

PMID:
11500230
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center